Japanese Patent Intelligence

Drug Screening 33% Faster: High-Precision Bile Duct Model Accelerates R&D

~$0.5M/year estimated R&D cost savings per facility (est.)

Natural Compound Reduces Depression by ~25%, Boosts Physical Activity

~$34.5M/year estimated new market creation and productivity improvement (est.)

Alzheimer's Dual Inhibition: Targets Tau Pathology for ~$650M Annual Impact

~$650M/year estimated revenue potential within a new market segment (est.)

Accelerate Citrus Breeding by 50%, Cut Costs by ~$150K Annually

~$150K/year estimated breeding cost reduction per facility (est.)

Green Hydrogen from Waste: Cut Costs ~$330K/year, Zero Inhibitors

~$350K/year estimated cost reduction per facility (AI est.)

Seaweed Biorefinery: ~30% Cost Cut, 20% CO2 Reduction in KDG Production

~$1.0M/year estimated cost savings and new revenue per facility (est.)

10x Higher Sensitivity: Rapid Pathogen Detection for Early Intervention

~$250K/year estimated cost reduction per facility (est.)

Bio-based 4-ACA: 70% Greener, 66% Cheaper Raw Materials

~$1M/year estimated manufacturing cost reduction per facility (est.)

Precision Phosphorylation Control: Accelerate Drug Development by 5%, Cut R&D Costs by ~$7M

~$7M/year estimated R&D cost reduction per facility (est.)

New Phage Therapy: Cuts Ocular Infection Costs by ~$1M Annually, Targets AMR

~$1M/year estimated medical cost savings per facility (est.)

OA Pain: miR-21 Inhibition Offers Long-Term Relief, ~$100M Market Potential

~$100M/year estimated new market creation (est.)

Injectable Hydrogel: 20% Faster Delivery, Superior Substance Permeability

~$1.5M/year estimated medical cost reduction per facility (est.)

mRNA-Targeted Anti-Inflammatory: 3x Faster to Market, ~$20M Market Potential

~$20M/year estimated new market creation potential (est.)

Swallowing Sensor Production Costs Cut by ~66% with Rigid PCB Tech

~$330K/year estimated manufacturing cost reduction per facility (est.)

2x Bone Cell Production, Accelerating Regenerative Medicine by ~20%

~$0.5M–$3.5M/year estimated cost savings per facility (est.)

New CNS Therapy Targets Mitochondrial Dysfunction, Unlocking ~$65M Market Potential

~$65M/year estimated new market creation potential (est.).

iPS Cell Safety Breakthrough: ~99% Contamination Cut, Accelerating Regenerative Medicine

~$1M/year estimated safety validation cost reduction per facility (est.)

3D Digital Denture Manufacturing: 3x Stronger Bonds, 67% Faster Production

~$1M/year estimated manufacturing cost savings per facility (est.)

Non-Invasive 3D Joint Models: Boost Treatment Accuracy by >5%, Cut Recovery Time

~$1.5M/year estimated medical cost reduction per facility (est.)

Novel Compound Cuts Myocardial Damage by ~20%, Reduces Hospital Stays

~$16.5M/year estimated total healthcare cost reduction (est.)

Natural Microcapsules Enable Precision Release, Cut Material Costs by ~10%

~$1.5M/year estimated early revenue and cost savings per facility (est.)

Targeted Drug Delivery: Boost Efficacy, Cut R&D Costs by ~$1.5M Annually

~$1.5M/year estimated R&D cost reduction and revenue opportunity per project (est.)

Accelerate Kidney Disease R&D by 3 Years, Cut Costs by ~$1M

~$1M estimated total cost reduction per project (est.)

Electromagnetic Fields Boost Particle Beam Precision by ~20%, Accelerating R&D by 30%

~$2M/year estimated medical cost reduction and research period shortening per facility (est.)